Skip to main content
Log in

Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

The nature of senile plaques (SP) in 27 cases of diffuse Lewy body disease (LBD) was investigated using immunocytochemistry and antibodies to beta amyloid protein synthetic peptides (BetaSP), ubiquitin (UBQ), paired helical filaments (PHF; Ab39) and a 68-kDa protein in Alzheimer brains (Alz50). Lewy bodies were present in widespread areas of the neocortex of all cases and were more easily detected with ubiquitin immunocytochemistry than with conventional stains. All cases had neocortical SP, but only six cases had neocortical neurofibrillary tangles (NFT). SP were very numerous in most cases and were usually “pale”, “diffuse” or “very primitive” plaques with thioflavin S fluorescent microscopy. SP in diffuse LBD were immunostained with BetaSP. Several cases had extensive amyloid angiopathy that was also immunoreactive with BetaSP. SP in diffuse LBD were characterized by amyloid deposits with few or no neuritic elements that could be detected with thioflavin S, Bielschowsky's stain or double staining with BetaSP and Bodian's silver stain. They differed from plaques in Alzheimer's disease by lack of PHF-type neurites that could be stained with Ab39. In diffuse LBD, SP contained PHF-type neurites only in areas coexistent with NFT. Some SP had round, granular neurites that were immunoreactive with UBQ, but weakly argyrophilic with Bodian's stain and nonfluorescent with thioflavin S. Diffuse LBD lacked significant neuritic change in the neuropil that could be detected with UBQ, Ab39 and Alz50. The latter finding is a characteristic feature that distinguishes Alzheimer's disease from diffuse LBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bancher C, Lassmann H, Budka H, Jellinger K, Grundke-Iqbal I, Iqbal K, Wiche G, Seitelberger F, Wisniewski HM (1989) An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 48:81–93

    Google Scholar 

  2. Beal MF, Mazurek MF, Martin JB (1986) Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer changes. Brain Res 397:386–388

    Google Scholar 

  3. Braak H, Braak E, Grundke-Iqbal I, Iqbal K (1986) Occurence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65:351–355

    Google Scholar 

  4. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA (1988) Diffuse Lewy body disease and progressive dementia. Neurology 38:1520–1528

    Google Scholar 

  5. Byrne EJ, Lowe J, Godwin-Austen RB, Arie T, Jones R (1987) Dementia and Parkinson's disease associated with diffuse cortical Lewy bodies. Lancet I:501

    Google Scholar 

  6. Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA (1986) The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. Brain Res 70:105–130

    Google Scholar 

  7. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu F, Kawas C, Aronson M, Wolfson L (1988) Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38:1682–1687

    Google Scholar 

  8. Crystal H, Davies P, Dickson DW (1988) Neuropsychological characteristics of subjects with and without Alz50 immunoreactivity. Alzheimer Related Dis Assoc J 2:171

    Google Scholar 

  9. Dickson DW, Kress Y, Crowe A, Yen S-H (1985) Monoclonal antibodies to Alzheimer neurofibrillary tangles. II. Demonstration of a common antigenic determinant between ANT and neurofibrillay degeneration in progressive supranuclear palsy. Am J Pathol 120:292–302

    Google Scholar 

  10. Dickson DW, Yen S-H, Suzuki KI, Davies P, Garcia JH, Hirano A (1986) Ballooned neurons in select neurodegenerative disease contain phosphorylated neurofilament epitopes. Acta Neuropathol (Berl) 71:216–223

    Google Scholar 

  11. Dickson DW, Davies P, Mayeux R, Crystal H, Horoupian DS, Thompson A, Goldman JE (1987) Diffuse Lewy body disease: neuropathological and biochemical studies of six patients. Acta Neuropathol (Berl) 75:8–15

    Google Scholar 

  12. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SHC (1988) Alzheimer's disease: a double-labeling immunohistochemical study of senile plaques. Am J Pathol 132:86–101

    Google Scholar 

  13. Dickson DW, Farlo J, Yen SH, Crystal H, Fuld P, Davies P (1988) Clinicopathologic and immunocytochemical studies on demented and nondemented individuals distinguishes two classes of senile plaques. J Neuropathol Exp Neurol 47:381 [abstr]

    Google Scholar 

  14. Ditter SM, Mirra SS (1987) Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 37:754–760

    Google Scholar 

  15. Epelbaum J, Ruberg M, Moyse E, Javoy-Agid F, Dubois B, Agid Y (1983) Somatostatin and dementia in Parkinson's disease. Brain Res 278:376–379

    Google Scholar 

  16. Forno LS (1969) Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to Parkinsonism. J Am Geriatr Soc 17:557–575

    Google Scholar 

  17. Forno LS, Sternberger LA, Sternberger NH, Strefling AM, Swanson K, Eng LF (1986) Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett 64:253–258

    Google Scholar 

  18. Fuld PA, Dickson DW, Crystal H, Aronson MK (1987) Primitive plaques and memory dysfunction in normal and impaired elderly. N Engl Med 316:756

    Google Scholar 

  19. Galloway PG, Grundke-Iqbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47:654–663

    Google Scholar 

  20. Gibb WRG (1986) Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol Appl Neurobiol 12:223–234

    Google Scholar 

  21. Gibb WRG, Luthert PJ, Janota I, Lantos PL (1989) Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 52:185–192

    Google Scholar 

  22. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745–752

    Google Scholar 

  23. Gibb WRG, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110:1131–1153

    Google Scholar 

  24. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890

    Google Scholar 

  25. Goldman JE, Yen S-H, Chiu F-C, Peress NS (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221:1082–1084

    Google Scholar 

  26. Hyman BT, VanHoesen GW, Wolozin BI, Davies P, Kromer LJ, Damasio AR (1988) Alz50: recognition of Alzheimerrelated neuronal changes that precede neurofibrillary tangle formation. Ann Neurol 23:371–379

    Google Scholar 

  27. Ikeda S-I, Allsop D, Glenner GG (1989) Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. Lab Invest 60:113–122

    Google Scholar 

  28. Jellinger K (1986) Overview of morphological changes in Parkinson's disease. Adv Neurol 45:1–18

    Google Scholar 

  29. Jolkkonen J, Soininen H, Halonen T, Ylinen A, Laulumaa V, Laakso M, Riekkinen P (1986) Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. J Neurol Neurosurg Psychiatry 49:1374–1377

    Google Scholar 

  30. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230–236

    Google Scholar 

  31. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree — a new disease? Clin Neuropathol 3:185–192

    Google Scholar 

  32. Kosaka K, Tsuchiya K, Yoshimura M (1988) Lewy body disease with and without dementia: a clinicopathologic study of 35 cases. Clin Neuropathol 7:299–305

    Google Scholar 

  33. Kuroda S, Otsuki S, Hayashi Y (1987) Diffuse Lewy body disease: an autopsy case. Acta Med Okayama 41:133–139

    Google Scholar 

  34. Ksiezak-Reding H, Davies P, Yen S-H (1988) Alz50, a monoclonal antibody to Alzheimer's disease antigen, crossreacts with tau proteins from bovine and normal human brain. J Biol Chem 263:7943–7947

    Google Scholar 

  35. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y (1988) Lewy bodies are ubiquitinated: a light and electron microscopic immunocytochemical study. Acta Neuropathol (Berl) 75:345–353

    Google Scholar 

  36. Lee S, Park YD, Yen S-H, Ksiezak-Reding H, Goldman JE, Dickson DW (1989) Infantile motor neuron disease: a case report with electron microscopic and ubiquitin and neurofilament immunohistochemical studies. Neuropediatrics 20:107–111

    Google Scholar 

  37. Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ (1989) Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 52:67–71

    Google Scholar 

  38. Leverenz J, Sumi M (1986) Parkinson's disease in patients with Alzheimer's disease. Arch Neurol 43:662–664

    Google Scholar 

  39. Manetto V, Perry G, Tabaton M, Mulvihill P, Fried VA, Smith HT, Gambetti P, Autillo-Gambetti L (1988) Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative disease. Proc Natl Acad Sci USA 85:4501–4505

    Google Scholar 

  40. Okazaki H, Lipkin LE, Aronson SM (1961) Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 3:237–243

    Google Scholar 

  41. Ogomori K, Kitamoto T, Tateishi J, Sato Y, Suetsugu M, Abe M (1989) Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 134:243–251

    Google Scholar 

  42. Pappolla MA (1986) Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments. Arch Pathol Lab Med 110:1160–1163

    Google Scholar 

  43. Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 48:413–421

    Google Scholar 

  44. Perry G, Manetto V, Mulvihill P (1987) Ubiquitin in Alzheimer and other neurodegenerative disease. In: Perry G (ed) Alterations in the neuronal cytoskeleton in Alzheimer disease. Plenum, New York, pp 53–59

    Google Scholar 

  45. Rosenblum WI, Ghatak NR (1979) Lewy bodies in the presence of Alzheimer's disease. Arch Neurol 36:170–171

    Google Scholar 

  46. Sima AAF, Clark AW, Sternberger NA, Sternberger LA (1986) Lewy body dementia without Alzheimer changes. Can J Neurol Sci 13:490–497

    Google Scholar 

  47. Schwartz P (1970) Amyloidosis: cause and manifestation of senile deterioration. Thomas, Springfield, Ill, pp 43–61

    Google Scholar 

  48. Ulrich J (1985) Alzheimer changes in nondemented patients younger than sixty-five. A possible early stage of Alzheimer's disease and senile dementia of the Alzheimer type. Ann Neurol 17:273–277

    Google Scholar 

  49. Wolozin BL, Davies P (1987) Alzheimer-related neuronal protein A68: specificity and distribution. Ann Neurol 22:521–526

    Google Scholar 

  50. Wolozin BL, Pruchnicki A, Dickson DW, Davies P (1986) A neuronal antigen in the brain of Alzheimer patients. Science 232:648–650

    Google Scholar 

  51. Wolozin B, Scicutella A, Davies P (1988) Reexpression of a developmentally regulated antigen in Down's syndrome and Alzheimer disease. Proc Natl Acad Sci USA 85:6202–6206

    Google Scholar 

  52. Yamaguchi H, Hirai S, Morimatsu M, Shogji M, Ihara Y (1988) A variety of cerebral amyloid deposits in the brain of the Alzheimer type dementia demonstrated by beta protein immunostaining. Acta Neuropathol 76:541–549

    Google Scholar 

  53. Yamamoto T, Imai T (1988) A case of diffuse Lewy body and Alzheimer's disease with periodic synchronous discharges. J Neuropathol Exp Neurol 47:536–548

    Google Scholar 

  54. Yen S-H, Crowe A, Dickson DW (1985) Monoclonal antibodies to Alzheimer neurofibrillary tangles. I. Identification of polypeptides. Am J Pathol 120:282–291

    Google Scholar 

  55. Yen S-H, Dickson DW, Peterson C, Goldman JE (1986) Cytoskeletal abnormalities in neuropathology. Prog neuropathol 6:63–90

    Google Scholar 

  56. Yoshimura N, Yoshimura I, Asada M, Hayashi S, Fukushima Y, Sato T, Kudo H (1988) Juvenile Parkinson's disease with widespread Lewy bodies in the brain. Acta Neuropathol 77:213–218

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grant NIA AG06803

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dickson, D.W., Crystal, H., Mattiace, L.A. et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 78, 572–584 (1989). https://doi.org/10.1007/BF00691284

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00691284

Key words

Navigation